Get Your Personalized Supplement StackSupplement Stack Quiz

Organic Cordyceps Mushroom Fruiting Body Extract

Also known as: Cordyceps mushroom, caterpillar fungus, Cordyceps sinensis, Cordyceps militaris

Overview

Cordyceps mushroom fruiting body extract is derived from the fruiting bodies of *Cordyceps militaris*, a parasitic fungus traditionally used in Asian ethnomedicine. It contains bioactive compounds such as cordycepin, polysaccharides, ergothioneine, and GABA. Traditionally, it has been used for fatigue reduction, immune stimulation, and as an adaptogen. Modern research explores its potential ergogenic (performance-enhancing), anti-inflammatory, antioxidant, antiviral, and cardioprotective effects. The research maturity for Cordyceps is moderate, with numerous in vitro and animal studies, some human clinical trials, and a few systematic reviews/meta-analyses, particularly on *Cordyceps sinensis* preparations. While some randomized controlled trials (RCTs) exist, they often have small to moderate sample sizes, indicating a need for larger, high-quality studies to confirm benefits.

Benefits

Cordyceps offers several evidence-based benefits. It may act as an ergogenic aid and reduce fatigue by potentially increasing ATP production, improving muscle energy and recovery. A small human RCT (n=14) showed 1g of Cordyceps supplementation reduced muscle damage and accelerated repair post-exercise. It also exhibits immune-modulating effects, with extracts suppressing pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) and enhancing immune response markers (IL-12, IFN-γ) in vitro and in small human studies. Polysaccharides and cordycepin contribute to its antioxidant and anti-inflammatory properties, reducing oxidative stress and inflammation markers in preclinical models. Cardioprotective effects have been observed in animal studies, where cordycepin inhibited platelet aggregation and protected ischemic heart tissue. Secondary effects include potential antiviral activity, including against COVID-19 related targets, and hypolipidemic effects in animal models. For specific populations, some evidence suggests improved lung function and exercise endurance in COPD patients with *Cordyceps sinensis* preparations, though these studies are small and heterogeneous. While meta-analyses indicate modest improvements, larger trials are needed to confirm ergogenic effects in healthy adults.

How it works

Cordyceps exerts its effects primarily through its bioactive compounds, notably cordycepin and polysaccharides. Cordycepin acts as an adenosine analogue, influencing ATP-related pathways, which contributes to its potential ergogenic effects by enhancing cellular energy. It also modulates cGMP/cAMP pathways to inhibit platelet aggregation and suppresses inflammatory mediators like nitric oxide (NO), TNF-α, and IL-6. Polysaccharides, another key component, are involved in modulating immune cell activity and reducing oxidative stress. These compounds interact with various biological pathways, including those involved in cytokine production, platelet aggregation, and oxidative stress, to produce their observed benefits. While cordycepin is bioactive, human data on its oral bioavailability is limited, and polysaccharides may act partially through gut immune modulation.

Side effects

Cordyceps is generally well tolerated, with few adverse events reported in clinical trials. Common side effects are rare and typically mild, primarily involving mild gastrointestinal discomfort. Dry mouth and headache have been reported, but their direct link to Cordyceps is considered unlikely given their very low incidence. No significant uncommon or rare side effects have been reported in high-quality studies. Potential theoretical drug interactions exist with anticoagulants due to Cordyceps' observed platelet aggregation inhibition in preclinical studies; however, strong clinical evidence for this interaction is lacking. Therefore, caution is advised for individuals with bleeding disorders or those concurrently taking anticoagulant medications. Data on special populations is limited, but studies in COPD patients have not revealed major safety concerns. Overall, Cordyceps appears to have a favorable safety profile at commonly studied dosages.

Dosage

Human studies on Cordyceps have utilized varying dosages, with 1 gram per day of fruiting body extract showing effects for ergogenic purposes. Optimal dosage ranges commonly fall between 1-3 grams per day in clinical trials. The maximum safe dose is not well established, but no toxicity has been reported at the dosages studied. For acute benefits, such as exercise recovery, pre-exercise dosing has shown effects. However, for immune and antioxidant benefits, daily dosing over several weeks is likely required to observe effects. It is important to note that fruiting body extracts are generally preferred over mycelium due to their higher concentration of key bioactive compounds like cordycepin. While specific absorption factors are not fully identified, co-administration with food may influence absorption.

FAQs

Is Cordyceps safe for daily use?

Yes, Cordyceps is generally considered safe for daily use, with clinical trials reporting minimal side effects.

Does it improve athletic performance?

Some preliminary human evidence suggests it may improve exercise recovery and energy metabolism, but larger, well-designed studies are needed to confirm these effects.

How long does it take to see benefits?

Acute effects, such as those related to exercise, may be observed quickly. However, immune and antioxidant benefits typically require consistent daily supplementation for several weeks.

Is fruiting body extract better than mycelium?

Yes, fruiting body extracts are generally preferred as they contain higher concentrations of key bioactive compounds like cordycepin compared to mycelium.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC8622900/ – This source discusses the antiviral potential of Cordyceps, specifically highlighting cordycepin's activity against COVID-19 related targets. It provides insights into the molecular mechanisms and potential therapeutic applications of Cordyceps in viral infections.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7104994/ – This article provides a comprehensive review of Cordyceps' immunomodulatory, antioxidant, and anti-inflammatory properties. It details how polysaccharides and cordycepin reduce oxidative stress and inflammation markers in various models, supporting its traditional uses.
https://wjarr.com/sites/default/files/WJARR-2024-0767.pdf – This source, citing Cho et al., 2006 and Park et al., 2014, provides preclinical data on Cordyceps. It highlights how cordycepin inhibits platelet aggregation and protects ischemic heart tissue in animal models, suggesting cardioprotective effects.
https://onlinelibrary.wiley.com/doi/10.1155/2019/4903671 – This systematic review and meta-analysis by Yu et al., 2019, evaluates the effects of Cordyceps sinensis in COPD patients. It suggests modest improvements in lung function, exercise endurance, and quality of life, though it notes limitations due to small sample sizes and heterogeneity in the included studies.
https://www.healthline.com/nutrition/cordyceps-benefits – This source references a recent human RCT (2024) indicating that 1 gram of Cordyceps reduced muscle damage and accelerated recovery post-exercise in young adults. While preliminary due to its small sample size and short duration, it provides initial human evidence for ergogenic benefits.